Old Web
English
Sign In
Acemap
>
Paper
>
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.
2021
Giorgia Bruno
Bernadette Donnarumma
Alessia Inverardi
P. Buonpensiero
Angela Sepe
Antonella Tosco
Valeria Raia
Antonio Varone
Keywords:
Spinal muscular atrophy
Pathology
Cystic fibrosis
Nusinersen
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
0
Citations
NaN
KQI
[]